Linagliptin recommended for approval in the treatment of type 2 diabetes
24 June 2011 | By Boehringer Ingelheim
Boehringer Ingelheim and Eli Lilly received a positive opinion from the EMA's medicinal committee...
List view / Grid view
News
Bristol-Myers Squibb Foundation awards $1.5 million in grants to help African American women fight type 2 diabetes
24 June 2011 | By Bristol-Myers Squibb
The Bristol-Myers Squibb Foundation awarded five grants totaling $1.5 million...
Roche and Evotec to jointly develop biomarkers in oncology
24 June 2011 | By Roche
Roche and Evotec AG announced a collaboration in novel protein-activity based biomarkers for Roche’s oncology drugs...
FDA Complete Response Letter received for REMOXY
24 June 2011 | By Pfizer
Pfizer & Pain Therapeutics, Inc. received a Complete Response Letter from the U.S. FDA...
Sanofi Pasteur’s Typhim Vi®, granted prequalification by the WHO
23 June 2011 | By Sanofi Pasteur
Sanofi Pasteur, announced that the WHO has granted prequalification to its Typhim Vi® polysaccharide typhoid vaccine...
GSK statement on agreements with State Attorneys General on former Cidra manufacturing facility
23 June 2011 | By GlaxoSmithKline
GSK has agreed to pay $40.75 million, as part of an agreement...
Roche sets up R&D Institute in France to foster collaborative translational research
23 June 2011 | By Roche
Roche announced the launch of a new R&D Institute in France...
Novo Nordisk invests 1 billion Danish kroner in new factory in Denmark
22 June 2011 | By Novo Nordisk
Novo Nordisk is investing close to 1 billion Danish kroner (134 million euros) in a new factory in Kalundborg, Denmark...
Aesica appoints new European Manager
22 June 2011 | By Velvet Communications Limited
Aesica Pharmaceuticals has announced the appointment of Nicolas Micheaud as Regional Sales Manager – Western Europe...
Sanofi establishes a global agreement with Medco and UBC
22 June 2011 | By Sanofi
To better leverage the real-world evidence generated during product development and throughout the product lifecycle...
AstraZeneca to sell AstraTech to DENTSPLY International
22 June 2011 | By AstraZeneca
AstraZeneca has agreed to sell its Astra Tech business to DENTSPLY for approximately $1.8 billion in cash...
Novozymes Biopharma to present on creating market opportunities through drug half-life extension
22 June 2011 | By The Scott Partnership
Novozymes Biopharma, will host a panel session at the BIO Business Forum...
BYDUREON™ receivies marketing authorisation in Europe
21 June 2011 | By Eli Lilly and Company
Eli Lilly and Company, together with Amylin Pharmaceuticals, Inc. and Alkermes, Inc., announced that the European Commission has granted marketing authorization to BYDUREON™...
Pfizer selects Exco InTouch’s novel eDiary technologies to initiate first ever Patient-Centered clinical trial
21 June 2011 | By The Scott Partnership
Exco InTouch, announced that its novel eDiary technologies have been selected by Pfizer...
ERT appoints Robert Kleiman MD to Chief Medical Officer
21 June 2011 | By ERT
ERT, announced that Robert Kleiman, has been appointed to the role of Chief Medical Officer...
